The Copaxone Battle
Arguments over the term of the patents granted are at the heart of the Copaxone conflict, says Archana Shanker. Copaxone (glatiramer acetate) is a blockbuster
Celebrating World IP Day with a GI Party
What better way to celebrate Word IP Day than to celebrate it! India is known to be rich in its culture and heritage, spawning a large number of geographical
Sweet Success
How a temple prevailed in the battle over a geographical indication for its famous confection, Tirupati laddus. In February 2014, a four-page order by
Same same but different
The legality of parallel imports remains a grey area in India, write Pravin Anand and Nishchal Anand. The evolution of the law relating to parallel imports
Enforcing Pharmaceutical Patents in India: A Case Study of the Sitagliptin Litigation
April 2014 marks the first anniversary of the judgment of the Indian Supreme Court in the Novartis case, wherein the decision of the Indian Patent Office
Is the Creative Community Satisfied with the Copyright Act 2012?
Rahul Ajatshatru explores the amendments contained in the Copyright (Amendment) Act 2012 and to what extent the parliament has been successful in empowering authors
Hunting Down India’s Nameless Infringers
Technology has made IP infringement easier, and more nameless, than ever before, and getting John Doe orders against unidentified infringers is essential.
The Nightmare of Section 8
Due in part to its often-ambiguous requirements, Section 8 of India’s Patents Act has become a nightmare for patent owners, explains Pravin Anand.
Fashion law: A Guide for Designers, Fashion Executives & Attorneys
Safir Anand talks about the key legal issues for fashion companies in India in ‘Fashion Law – A Guide for Designers, Fashion Executives &
Domain Name Dispute Resolution: An Indian Perspective
With ever-increasing premiums for domain names differences between Indian and international dispute resolution policies are cause for concern, explain
etc. whilst wrongfully claiming to be part of our firm and making false claims and allegations.